AR108718A2 - Composición - Google Patents
ComposiciónInfo
- Publication number
- AR108718A2 AR108718A2 ARP170101607A ARP170101607A AR108718A2 AR 108718 A2 AR108718 A2 AR 108718A2 AR P170101607 A ARP170101607 A AR P170101607A AR P170101607 A ARP170101607 A AR P170101607A AR 108718 A2 AR108718 A2 AR 108718A2
- Authority
- AR
- Argentina
- Prior art keywords
- lipopolysaccharide
- adjuvant
- saponin
- human dose
- composition
- Prior art date
Links
- 239000002671 adjuvant Substances 0.000 abstract 3
- 239000002158 endotoxin Substances 0.000 abstract 3
- 229920006008 lipopolysaccharide Polymers 0.000 abstract 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 abstract 3
- 229930182490 saponin Natural products 0.000 abstract 3
- 150000007949 saponins Chemical class 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 239000002502 liposome Substances 0.000 abstract 2
- 241001092142 Molina Species 0.000 abstract 1
- 241001454523 Quillaja saponaria Species 0.000 abstract 1
- 235000009001 Quillaja saponaria Nutrition 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
Dosis humana de una composición inmunogénica que comprende un antígeno o preparación antigénica, en combinación con un coadyuvante, comprendiendo dicho coadyuvante una fracción inmunológicamente activa de saponina derivada de la corteza de Quillaja Saponaria Molina presentada en forma de un liposoma y un lipopolisacárido, en el que dicha fracción de saponina y dicho lipopolisacárido están ambos presentes en dicha dosis humana a un nivel menor de 30 mg. Composición coadyuvante en un volumen adecuado para dosis humana que comprende entre 1 y 30 mg de un lipopolisacárido y entre 1 y 30 mg de una fracción inmunológicamente activa de saponina presentada en forma de un liposoma.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0525321.6A GB0525321D0 (en) | 2005-12-13 | 2005-12-13 | Novel compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR108718A2 true AR108718A2 (es) | 2018-09-19 |
Family
ID=35736013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170101607A AR108718A2 (es) | 2005-12-13 | 2017-06-13 | Composición |
Country Status (5)
| Country | Link |
|---|---|
| CN (1) | CN101330924A (es) |
| AR (1) | AR108718A2 (es) |
| GB (1) | GB0525321D0 (es) |
| UA (1) | UA98612C2 (es) |
| ZA (1) | ZA200805025B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101690810B (zh) * | 2009-10-21 | 2011-08-17 | 辽宁益康生物股份有限公司 | 一种鸡新城疫、传染性支气管炎、减蛋综合征、禽流感四联灭活疫苗佐剂及其制备方法 |
| US20140072622A1 (en) * | 2011-05-17 | 2014-03-13 | Glaxosmithkline Biologicals S.A. | Vaccine against streptococcus pneumoniae |
| GB201213364D0 (en) * | 2012-07-27 | 2012-09-12 | Glaxosmithkline Biolog Sa | Purification process |
| CN104884081A (zh) * | 2012-12-05 | 2015-09-02 | 葛兰素史密丝克莱恩生物有限公司 | 免疫原性组合物 |
| TW201601750A (zh) * | 2013-10-03 | 2016-01-16 | Nitto Denko Corp | 注射疫苗組合物 |
| CN108853493A (zh) * | 2018-07-26 | 2018-11-23 | 中国人民解放军陆军军医大学 | 麦冬皂苷d及其纳米乳在制备疫苗佐剂中的应用 |
-
2005
- 2005-12-13 GB GBGB0525321.6A patent/GB0525321D0/en not_active Ceased
-
2006
- 2006-12-12 UA UAA200807167A patent/UA98612C2/uk unknown
- 2006-12-12 CN CNA2006800471395A patent/CN101330924A/zh active Pending
-
2008
- 2008-06-09 ZA ZA200805025A patent/ZA200805025B/xx unknown
-
2017
- 2017-06-13 AR ARP170101607A patent/AR108718A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101330924A (zh) | 2008-12-24 |
| GB0525321D0 (en) | 2006-01-18 |
| UA98612C2 (uk) | 2012-06-11 |
| ZA200805025B (en) | 2009-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR058543A1 (es) | Nueva composicion de vacuna potenciada con un adyuvante liposomal | |
| AR108718A2 (es) | Composición | |
| UA94900C2 (uk) | Вакцина | |
| CO6440528A2 (es) | Composiciones adyuvantes que comprenden un agente de isotonicidad no iónico. | |
| ES2528665T3 (es) | Fabricación de vacunas amplificadoras que tienen dosis de antígeno reducidas | |
| CR11122A (es) | Vacuna de influenza de emulsion de aceite en agua | |
| CR10726A (es) | Vacuna que comprende un adyuvante de emulsion de aceite en agua | |
| ES2585810T3 (es) | Uso de un virus de la gripe y un adyuvante de emulsión de aceite en agua para inducir respuesta de células T CD4 y/o una respuesta de células B de memoria mejorada | |
| ECSP10010723A (es) | Vacuna de vesícula de membrana externa nativa multivalente del meningococo, método para su fabricación y uso | |
| CR10123A (es) | Vacuna. | |
| MXPA05013973A (es) | Metodos para producir, mejorar y sustentar respuestas inmunes contra epitopes restringidos mhc clase i, para propositos profilacticos o terapeuticos. | |
| AR082952A1 (es) | Variantes no lipidadas de antigenos orf2086 de neisseria meningitidis | |
| HK1199711A1 (en) | Bioconjugate vaccines made in prokaryotic cells | |
| ES2195169T3 (es) | Vacunas contra calmidias y composiciones inmunogenicas que contienen un antigeno de membrana externa y metodos para su preparacion. | |
| AR109263A2 (es) | Composición que comprende moxidectina | |
| SG158154A1 (en) | Methods to elicit, enhance and sustain immune responses against mhc class i-restricted epitopes, for prophylactic or therapeutic purposes | |
| WO2010039924A3 (en) | Th1 vaccination priming for active immunotheraphy | |
| AR023536A1 (es) | Vacunas | |
| EP2433648A3 (en) | Vaccine comprising an oil in water emulsion adjuvant | |
| AR048355A1 (es) | Asociacion entre un compuesto heterociclico y un agente antioxidante y las composiciones farmaceuticas que los contienen | |
| DOP2009000068A (es) | Vacuna que comprende un adyuvante de emulsión de aceite en agua | |
| BRPI0501904A (pt) | Vacina para controle de carrapatos boophilus microplus e processo para sua preparação | |
| NZ611463A (en) | Inactivated dengue virus vaccine with aluminium-free adjuvant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |